CN101554431A - Medicament for pain-alleviating and treating rheumatoid disease and preparation method thereof - Google Patents

Medicament for pain-alleviating and treating rheumatoid disease and preparation method thereof Download PDF

Info

Publication number
CN101554431A
CN101554431A CNA2008100666229A CN200810066622A CN101554431A CN 101554431 A CN101554431 A CN 101554431A CN A2008100666229 A CNA2008100666229 A CN A2008100666229A CN 200810066622 A CN200810066622 A CN 200810066622A CN 101554431 A CN101554431 A CN 101554431A
Authority
CN
China
Prior art keywords
medicine
preparation
chinese
manshanxiang
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2008100666229A
Other languages
Chinese (zh)
Inventor
肖春刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2008100666229A priority Critical patent/CN101554431A/en
Publication of CN101554431A publication Critical patent/CN101554431A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for pain-alleviating and treating rheumatoid disease, which comprises traditional Chinese medicine and lysozyme prepared by the following weight ratios: 15-350 of schefflerae kwangsiensis, 10-250 of leaf of puberulent premna, 1000-4000 of samshu, 5-180 of gaultheria yunnanensis, 5-200 of herba solani nigri, 8-200 of desmodium and 5-160 of kyllinga monocephala. The method for preparing the medicament comprises the following steps: manufacturing the samshu and placing the samshu in a container; pulverizing components of the traditional Chinese medicines into rough powder, evenly mixing and placing the rough powder in an airtight container, and heating and extracting the rough powder and the samshu for three times with 2.5 hours for the first time, 1.5 hours for the second time and 0.5 hours for the third time. The effective components of the medicament have no toxicity and have functions of alleviating pain and treatment with outstanding effect, thereby achieving the aim of completely treating the rheumatoid disease. The medicament has simple manufacture process, easy operation and low cost.

Description

A kind of medicine that is used for rheumatoid disease pain relieving and treatment and preparation method thereof
Technical field
The present invention relates to a kind of medicine and preparation method that is used for rheumatoid disease pain relieving and treatment, especially is medicine of feedstock production and preparation method thereof with Chinese medicine.
Background technology
Rheumatoid disease is the human stubborn disease of a kind of long-term puzzlement, rheumatoid arthritis wherein belongs to one of modal rheumatoid disease, be a kind of cause of disease not bright, based on arthritis chronic repeatedly the outbreak systemic disease, migration arthralgia, swelling and dysfunction are arranged in early days, then show as ankylosis and deformity late period, afunction causes the maimed person.Secondly pathological changes is histoorgans such as serous coat, the heart, lung and eye, skin, blood vessel, kidney mainly at synovium of joint.After small part patient's morbidity spontaneous remission trend is arranged.Most patient's state of an illness repeatedly, the time heavy when light.Other has the small part patient state of an illness to be lasting aggravation, and is rare static.
Suffer from this type of sick patients clinical and show as bones and muscles pain from head to foot more, handicapped, severe patient pain unbearably and joint swelling deformation occurs, even foot can not be walked, hands can not be done things, and completely loses work capacity.The cause of disease complexity that this type of is sick, majority are that the Therapeutic Method and the medication of each hospital are had nothing in common with each other because of due to blockage of main and collateral channels, the poor blood circulation, but all are nothing but inner take medicine and traditional Chinese medical science means such as combination physical therapy, external application medical ointment or massage are treated.What no matter adopt is the doctor trained in Western medicine or the Therapeutic Method of the traditional Chinese medical science, all is temporary transient mitigation symptoms, and mitigate the disease alleviates patient's misery, and treatment cycle is long, can not reach the purpose of radical cure.
In addition, rheumatoid disease is the chronic disease that perplexs patient for a long time and be difficult to cure, and main is that its complication that produces causes great injury to function of human body.It substantially all is the combination that common Chinese medicine is again and again changed slightly that prior art is treated rheumatoid Chinese medicine, and much medicine all has certain toxic substance, does not accomplish that prescription is appropriate, and the wound skill that consumption is reasonable and new does not more have peculiar curative effect.Some patient is after with the regular hour, because side effects of pharmaceutical drugs patient body each several part internal organs have certain damage, thereby brings new pathological changes.
Summary of the invention
The objective of the invention is to for overcoming the deficiencies in the prior art, and provide a kind of medicine that is used for rheumatoid disease pain relieving and treatment, this creator has broken through the kind of present conventional Chinese medicine under study for action, find and found the new treatment function and the reasonable combination method of some medicines, rheumatoid treatment is had breakthrough.This medicine has that cost is low, the outstanding effect characteristics; The present invention also provides the preparation method of this medicine.
The objective of the invention is to realize by following technical solution: a kind of medicine that is used for rheumatoid disease pain relieving and treatment, this medicine comprise Chinese medicine and the lyase by following weight ratio preparation: Radix Schefflerae Arboricolae 15-350, Folium premnae puberulae 10-250, Chinese liquor 1000-4000.
For medicine of the present invention has the effect of better pain relieving and treatment, can on the basis of above-mentioned composition, increase the Chinese medicine of following weight ratio: MANSHANXIANG 5-180, Herba Solani Surattensis 5-200.
For medicine of the present invention has the effect of better pain relieving and treatment, can on the basis of above-mentioned composition, increase the Chinese medicine of following weight ratio: Herba Lysimachiae 8-200, Herba Kylligac coloratae 5-160.
The preparation method of medicine of the present invention, comprise that step is as follows: (1) at first makes Chinese liquor, and Chinese liquor is placed in the container; (2) each Chinese medicinal ingredients is ground into coarse powder, mixing is put into hermetic container with Chinese liquor heating extraction three times, extracts 2.5 hours for the first time, extracts 1.5 hours for the second time, extracts for the third time 0.5 hour.When in the described pharmaceutical compositions MANSHANXIANG being arranged, be earlier MANSHANXIANG to be pulverized the back separately to filter with the Chinese liquor percolation, again behind three extracting liquid filterings of each Chinese medicinal ingredients that will be processed into through aforementioned preparation method with the percolate mixing of MANSHANXIANG.
In the compatibility of this medicine, the function of each composition is as follows respectively:
The Radix Schefflerae Arboricolae antalgic, promoting blood circulation and detumescence.Be used for rheumatalgia, premenstrual abdominal pain, neuralgia etc.
The Folium premnae puberulae wind-damp dispelling, invigorating kidney-YANG.Cure mainly rheumatic arthralgia, hypertrophic spondylitis, scapulohumeral periarthritis is suffered from a deficiency of the kidney
Sexual impotence, delayed period.
The MANSHANXIANG dispelling wind to relieve the exterior syndrome, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain.
Herba Solani Surattensis rushes down down, antidotes against snake bite.Cure mainly constipation, venom.
The Herba Lysimachiae eliminating damp-heat, treating stranguria, detumescence.
The Herba Kylligac coloratae dispelling wind, heat clearing away, cough-relieving, preventing the attack (or recurrence) of malaria, dissipating blood stasis, detumescence.
Most medicines have expelling wind and removing dampness in this prescription, promoting blood circulation and detumescence, numbness relieving and pain relieving, the effect of diuretic.--------anti-inflammatory analgetic----repairs soft tissue of joint cell (recovering the joint normal function) to the Shujin dissipating blood stasis to the mechanism of action that prescription is formed: inducing diuresis to remove edema.Each medical material effective active molecule composition cooperates with each other, Radix Schefflerae Arboricolae, and the strengthening bone and muscle analgesic antiphlogistic, its active ingredient is an organic acid, plays the pain relieving effect by the obvious inhibition to smooth muscle contraction, and the not side effect resemble the atropine.Herba Lysimachiae, eliminating damp-heat, detumescence has strengthened the circulation of other drug to diseased region blood such as joints, strengthens the good infiltration of pathological changes connective tissue to tissue fluid.MANSHANXIANG, its active ingredient is that the volatile oil of fragrance can well promote the organizational structure diastole, impel of the partial absorption of the drug molecule of other effective actives in the joint, improve the circulation of blood, have the effect that diminishes inflammation simultaneously, thereby make all medical materials of whole prescription form a unified treatment function.
The present invention's beneficial effect compared with prior art is: each active ingredient of medicine of the present invention does not all have toxicity, alleviates local muscular tone and diminishes inflammation simultaneously, has the effect of pain relieving and treatment, and effect is outstanding, can reach the purpose of thorough radical cure.The manufacturing process of medicine of the present invention is simple, and is easy to operate, and cost is low.
Below in conjunction with specific embodiment the present invention is further described.
The specific embodiment
In order to more fully understand technology contents of the present invention, technical scheme of the present invention is further introduced and explanation below in conjunction with specific embodiment.
Below be several composition formulation Example of medicine of the present invention, to prove absolutely technology contents of the present invention.
Embodiment 1
Medicine of the present invention comprises Chinese medicine and the lyase composition by following weight ratio preparation:
Radix Schefflerae Arboricolae 50,
Folium premnae puberulae 40,
Chinese liquor 1200.
Embodiment 2
Medicine of the present invention comprises Chinese medicine and the lyase composition by following weight ratio preparation:
Radix Schefflerae Arboricolae 60,
Folium premnae puberulae 45,
MANSHANXIANG 20,
Herba Solani Surattensis 15,
Chinese liquor 1800.
Embodiment 3
Medicine of the present invention comprises Chinese medicine and the lyase composition by following weight ratio preparation:
Radix Schefflerae Arboricolae 80,
Folium premnae puberulae 65,
MANSHANXIANG 30,
Herba Solani Surattensis 20,
Herba Lysimachiae 20,
Herba Kylligac coloratae 25,
Chinese liquor 2400.
Embodiment 4
Medicine of the present invention comprises Chinese medicine and the lyase composition by following weight ratio preparation:
Radix Schefflerae Arboricolae 120,
Folium premnae puberulae 80,
Herba Lysimachiae 30,
Herba Kylligac coloratae 60,
Chinese liquor 3000.
Embodiment 5
Medicine of the present invention comprises Chinese medicine and the lyase composition by following weight ratio preparation:
Radix Schefflerae Arboricolae 100,
Folium premnae puberulae 150,
MANSHANXIANG 30,
Herba Lysimachiae 40,
Herba Kylligac coloratae 50,
Chinese liquor 3500.
Embodiment 6
Medicine of the present invention comprises Chinese medicine and the lyase composition by following weight ratio preparation:
Radix Schefflerae Arboricolae 180,
Folium premnae puberulae 120,
MANSHANXIANG 60,
Herba Lysimachiae 70,
Herba Kylligac coloratae 50,
Chinese liquor 2800.
More than among each embodiment, the preparation method of medicine of the present invention, can adopt following steps:
(1) at first makes Chinese liquor, Chinese liquor is placed in the container; (2) each Chinese medicinal ingredients is ground into coarse powder, mixing is put into hermetic container with Chinese liquor heating extraction three times, extracts 2.5 hours for the first time, extracts 1.5 hours for the second time, extracts for the third time 0.5 hour.When in the described pharmaceutical compositions MANSHANXIANG being arranged, be earlier MANSHANXIANG to be pulverized the back separately to filter with the Chinese liquor percolation, again behind three extracting liquid filterings of each Chinese medicinal ingredients that will be processed into through aforementioned preparation method with the percolate mixing of MANSHANXIANG.Chinese liquor wherein is the edible distillate spirit of 50-60 degree.
The invention people has carried out research and the clinical practice more than 3 years more than 6 years to this invention medicine, in giving nearly 700 patient's medications, 311 routine patient's feedback informations wherein, situation about using is: male patient 174 people, age is at 30----62 between year, its significant curative effect of treatment (10 days each courses of treatment) through 2---4 the course of treatment is 158 people, and healing is 139 people; The women is 137 people, and between 34----70 year, its significant curative effect of treatment through 2---4 the course of treatment (each course of treatment 10 for day) is 125 people, and healing is 114 people.Through the treatment to above-mentioned 311 people, total effective rate reaches 90.1%; Cure rate reaches 81.4%.
The invention people is as the professional person of Chinese medicine, the traditional Chinese medicine of China there are research and the practice of several years, once arrived ground collection among the people special Chinese crude drugs all over China such as Guizhou, Yunnan and Changbai mountain, Jilin in person, develop a kind of medicine that is used for rheumatoid disease pain relieving and treatment of the present invention and preparation method thereof, that adopts is plant material with low cost, and its preparation method is fairly simple, and is easy to operate.For developing the advantage of Chinese traditional Chinese medicine,, special to the application the present invention of patent administration department in line with principle in order to allow the present invention can benefit more rheumatoid disease patient.
The above angle from specific embodiment discloses further to technology contents of the present invention; its purpose is to allow everybody be easier to understand technology contents of the present invention; but do not represent embodiments of the present invention and rights protection to be confined to this, the scope of the present invention should be as the criterion in claims of the present invention.

Claims (5)

1. medicine that is used for rheumatoid disease pain relieving and treatment is characterized in that this medicine comprises Chinese medicine and the lyase by following weight ratio preparation:
Radix Schefflerae Arboricolae 15-350,
Folium premnae puberulae 10-250,
Chinese liquor 1000-4000.
2. medicine according to claim 1 is characterized in that: the composition that also can add following weight ratio:
MANSHANXIANG 5-180,
Herba Solani Surattensis 5-200.
3. medicine according to claim 1 and 2 is characterized in that: the composition that also can add following weight ratio:
Herba Lysimachiae 8-200,
Herba Kylligac coloratae 5-160.
4. preparation method that is used for the medicine of rheumatoid disease pain relieving and treatment, its feature comprises that step is as follows:
(1) at first makes Chinese liquor, Chinese liquor is placed in the container;
(2) each Chinese medicinal ingredients is ground into coarse powder, mixing is put into hermetic container with Chinese liquor heating extraction three times, extracts 2.5 hours for the first time, extracts 1.5 hours for the second time, extracts for the third time 0.5 hour;
5. preparation method according to claim 4, it is characterized in that: when in the described pharmaceutical compositions MANSHANXIANG being arranged, be earlier MANSHANXIANG to be pulverized the back separately to filter with the Chinese liquor percolation, again behind three extracting liquid filterings of each Chinese medicinal ingredients that will be processed into through aforementioned preparation method with the percolate mixing of MANSHANXIANG.
CNA2008100666229A 2008-04-09 2008-04-09 Medicament for pain-alleviating and treating rheumatoid disease and preparation method thereof Pending CN101554431A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2008100666229A CN101554431A (en) 2008-04-09 2008-04-09 Medicament for pain-alleviating and treating rheumatoid disease and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2008100666229A CN101554431A (en) 2008-04-09 2008-04-09 Medicament for pain-alleviating and treating rheumatoid disease and preparation method thereof

Publications (1)

Publication Number Publication Date
CN101554431A true CN101554431A (en) 2009-10-14

Family

ID=41172813

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2008100666229A Pending CN101554431A (en) 2008-04-09 2008-04-09 Medicament for pain-alleviating and treating rheumatoid disease and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101554431A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101703586B (en) * 2009-11-06 2011-11-02 王保国 Medicament for treating rheumatism
CN103405612A (en) * 2013-08-01 2013-11-27 吴仕峰 TCM composition for treatment of periarthritis of shoulder and preparation method thereof
CN105663183A (en) * 2016-02-14 2016-06-15 湖南城市学院 Health-care medicinal liquor formula containing lysimachia capillipes hemsl component and preparation method

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101703586B (en) * 2009-11-06 2011-11-02 王保国 Medicament for treating rheumatism
CN103405612A (en) * 2013-08-01 2013-11-27 吴仕峰 TCM composition for treatment of periarthritis of shoulder and preparation method thereof
CN103405612B (en) * 2013-08-01 2015-03-25 吴仕峰 TCM composition for treatment of periarthritis of shoulder and preparation method thereof
CN105663183A (en) * 2016-02-14 2016-06-15 湖南城市学院 Health-care medicinal liquor formula containing lysimachia capillipes hemsl component and preparation method

Similar Documents

Publication Publication Date Title
CN102058673A (en) Chinese medicine composition for expelling wind and removing dampness and preparation method thereof
CN102973750B (en) Chinese traditional medicine for curing rheumatic, rheumatoid and gouty arthritis and cervical spondylosis
CN104258278A (en) Gushangling (for bone injury) spray
CN101181380A (en) Remedial medicament for relieving pain of rheumatism and preparation method thereof
CN101062198A (en) Decoction for treating arthritis
CN101554431A (en) Medicament for pain-alleviating and treating rheumatoid disease and preparation method thereof
CN104383445A (en) Traumatic injury analgesic
CN105726736A (en) Traditional Chinese medicine preparation for treating rheumatic arthritis, rheumatoid arthritis and scapulohumeral periarthritis
CN109303811A (en) The exterior-applied medical wine of activating microcirculation and removing stasis medicinal anti-inflammatory analgetic
CN103007159B (en) Chinese medicinal preparation for correcting pancreas islet function
CN102526275B (en) Pharmaceutical for curing gout and preparation method thereof
CN101869671A (en) Paste for waist, leg, shoulder and neck
CN101249173B (en) Traditional Chinese medicine preparation for curing gout and method of preparing the same
CN101129697A (en) Orally taken traditional Chinese medicine composition for treating atrophic arthritis
CN103751307B (en) A kind of external application analgesic Chinese patent medicine and preparation technology thereof
CN106540229A (en) A kind of exterior-applied medical wine for treating cold pain disease and preparation method thereof
CN101732507A (en) Formula of foot-soaking Chinese medicament for treating gout and preparation method thereof
CN104984313A (en) Traditional Chinese medicine medicinal wine for treating chilblain
CN1473612A (en) Paste for relieving swelling and alleviating pain and its producing method
CN103830360A (en) Channel-warming and vein-dredging medicinal liquor and preparation method thereof
CN102626479B (en) External-use Chinese herbal medicine composition for chronic rheumatism treatment
CN101322787B (en) Specific medicinal liquor for treating rheumatoild disease
CN105250613A (en) Medicine for treating chronic obstructive pulmonary disease in stable phase
CN101164591A (en) Wind-expelling dampness-removing medicinal composition and preparation method and use thereof
CN104815024A (en) Capsule for treating gout and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20091014